Dr. Nirmal Kumar Reddy Onteddu, MD

Dr. Onteddu practices at Flowers Hospital Breast Health Center in Dothan, Alabama.

Dr. Onteddu's NPI, 1629521075, was assigned on August 2, 2016. Dr. Onteddu graduated from Other in 2013. Dr. Onteddu's Alabama license number on file is MD.38489.

Dr. Onteddu's primary practice is Flowers Hospital Breast Health Center, at 4370 West Main St, Ste 101, Dothan, AL 36305. The practice phone is (334) 671-4908.

Dr. Onteddu's primary practice is Flowers Hospital Breast Health Center in Dothan, Alabama. Dr. Onteddu is also affiliated with Flowers Hospital. The medical group on file is Flowers Medical Group. Dmand AI also links Dr. Onteddu to 1 more hospital, 4 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Onteddu practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Onteddu's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Onteddu is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Onteddu's licenses on file in 3 states: Alabama, Florida and Texas.

Dmand AI lists acid reflux, arthritis, asthma, atrial fibrillation and flutter, bronchitis, cardiomyopathy, chronic diabetes and chronic hypertension among the conditions Dr. Onteddu treats.

CMS data shows 644 Medicare services from Dr. Onteddu across 11 procedure codes in 2024, for 290 Medicare patients. Medicare paid $44,033 for them.

CMS counts 290 Medicare patients who saw Dr. Onteddu in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Onteddu's median patient age at 69, with 54% women.

In 2024, Dr. Onteddu wrote 3,170 Medicare Part D claims for 339 patients. 83% of them were for generic drugs. CMS names the drug for 2,420 of them, across 62 drugs with 11 or more claims each, at $244,889 in total drug cost. In 2023, CMS named 324 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 60 out of 100 for Dr. Onteddu for performance year 2024, reported through an alternative payment model (APM). Dr. Onteddu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Onteddu, published from 2015 to 2025. 2023 was the busiest year, with 4. Dr. Onteddu has published most often in Cureus. Dr. Onteddu's most frequent co-authors are Sanjeeva P. Kalva, MD, Shohana Ahmed, MD and Zakaria Hindi.

CMS Open Payments shows 12 general payments to Dr. Onteddu from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $109.

Dr. Onteddu graduated from Other in 2013.

Dr. Onteddu is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.